Treatment of Patients With Neovascular AMD Using Indocyanine Green-Mediated Photothrombosis (i-MP).

Clinical trial NCT00331253 · UNKNOWN

Trial details

NCT number: NCT00331253
Sponsor: Opto Eletronica S.A.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Maculopathy, Age-Related

Start date: 2007-04-01
Enrollment: 280

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.